TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33338078

Group type: EXPERIMENTAL
Intervention: Service users’ experiences of ALRTIs and healthcare services
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Concordance approach to prescribing
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Support for service users to become reliable, subjective and agentic experts of their health
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Challenging power structures within healthcare, political and economic institutions
Number of subjects: 29
Study: 34550076

Group type: EXPERIMENTAL
Intervention: VB+FC (Virtual Badges + Facilitator Contact)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: VB+FC and VB+FC+online discussion board
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: VB (Virtual Badges)
Number of subjects: 602

Group type: COMPARATOR
Intervention: Intervention only conditions
Number of subjects: 602
Study: 33115428

Group type: EXPERIMENTAL
Intervention: Pharmacogenetic testing (PGx) for antidepressant prescribing
Number of subjects: 31
Study: 33969614

Group type: EXPERIMENTAL
Intervention: Mifepristone and misoprostol
Number of subjects: 711

Group type: COMPARATOR
Intervention: Misoprostol alone (control)
Number of subjects: 711
Study: 32091668

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 16328

Group type: EXPERIMENTAL
Intervention: Bivalirudin with routine GPI
Number of subjects: 16328

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 16328
Study: 36253920

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) as patient-site facilitators
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group with trained university student facilitators
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) group
Number of subjects: 28
Study: 33500177

Group type: EXPERIMENTAL
Intervention: Socioeconomic Townsend deprivation index (TDI)
Number of subjects: 501882

Group type: EXPERIMENTAL
Intervention: Genome-wide gene-by-environment interaction study
Number of subjects: 501882
Study: 35907824

Group type: EXPERIMENTAL
Intervention: NPWT (Avelle, Convatec™) applied to the perineal wound
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (historical cohort)
Number of subjects: 21
Study: 34366631

Group type: EXPERIMENTAL
Intervention: Modified Xiaochaihu Decoction (MXD) plus omeprazole simulation
Number of subjects: 288

Group type: COMPARATOR
Intervention: Omeprazole plus herbs simulation
Number of subjects: 288
Study: 35045208

Group type: EXPERIMENTAL
Intervention: LC51‐0255 (0.25, 0.5, 1, 2, or 4 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: LC51‐0255
Number of subjects: 50
Study: 35172273

Group type: EXPERIMENTAL
Intervention: StemPrintER Risk Score (SPRS)
Number of subjects: 776

Group type: COMPARATOR
Intervention: Oncotype DX Recurrence Score (RS)
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: StemPrintER Risk Score (SPRS) with Clinical Treatment Score (CTS)
Number of subjects: 776

Group type: COMPARATOR
Intervention: Oncotype DX Recurrence Score (RS) with Clinical Treatment Score (CTS)
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: StemPrintER Risk Score (SPRS) in node-negative patients with Clinical Treatment Score (CTS)
Number of subjects: 776

Group type: COMPARATOR
Intervention: Oncotype DX Recurrence Score (RS) in node-negative patients with Clinical Treatment Score (CTS)
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: StemPrintER Risk Score (SPRS) for late (5-10 years) distant recurrence (DR) prognostication
Number of subjects: 776

Group type: COMPARATOR
Intervention: Oncotype DX Recurrence Score (RS) for late (5-10 years) distant recurrence (DR) prognostication
Number of subjects: 776
Study: 35008112

Group type: EXPERIMENTAL
Intervention: Cold snare polypectomy (CSP)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Hot snare polypectomy (HSP)
Number of subjects: 425
Study: 34087542

Group type: EXPERIMENTAL
Intervention: Ignoring the comment
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Reassuring
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Reciprocating
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Challenging
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 156
Study: 35373443

Group type: COMPARATOR
Intervention: Active Monitoring (AM)
Number of subjects: 2565

Group type: EXPERIMENTAL
Intervention: Radical Prostatectomy (RP)
Number of subjects: 2565

Group type: EXPERIMENTAL
Intervention: External-Beam Radiotherapy (EBRT)
Number of subjects: 2565

Group type: EXPERIMENTAL
Intervention: Low-Dose-Rate Brachytherapy (BT)
Number of subjects: 2565
Study: 33300961

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus Vistusertib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus Everolimus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fulvestrant alone
Number of subjects: 0
Study: 35901408

Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cannabis abstinence
Number of subjects: 0
Study: 34228510

Group type: EXPERIMENTAL
Intervention: Geriatric assessment (GA)‐guided intervention
Number of subjects: 541
Study: 33750092

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin as primary anticoagulant
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Combination of assays to monitor heparin therapy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Viscoelastic tests
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Antithrombin replacement
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Platelet transfusion thresholds
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Willingness to participate in a randomized controlled trial
Number of subjects: 79
Study: 33116241

Group type: EXPERIMENTAL
Intervention: High density microarray patches (MAP)
Number of subjects: 12
Study: 35067772

Group type: EXPERIMENTAL
Intervention: Cannabis drops (first 6 weeks)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Cannabis oil drops (first 6 weeks)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cannabis drops (last 6 weeks)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Cannabis oil drops (last 6 weeks)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cannabis drops
Number of subjects: 6

Group type: COMPARATOR
Intervention: Cannabis oil drops
Number of subjects: 6
Study: 32992075

Group type: EXPERIMENTAL
Intervention: Intermediate-dose prophylactic anticoagulation
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard-dose prophylactic anticoagulation
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg daily
Number of subjects: 600

Group type: COMPARATOR
Intervention: Matching placebo for atorvastatin
Number of subjects: 600
Study: 35942505

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 980

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 980
Study: 34225698

Group type: EXPERIMENTAL
Intervention: Dynamic light intervention (daytime blue-enriched white light, CCT > 5000 K and blue-depleted light < 3000 K, 3 hours prior to sleep)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dynamic light intervention
Number of subjects: 24
Study: 35811080

Group type: EXPERIMENTAL
Intervention: Ivermectin for 3 days
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 32690406

Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Facilitated tucking
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no intervention mentioned)
Number of subjects: 80
Study: 32919516

Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35585641

Group type: EXPERIMENTAL
Intervention: Standard schizonticidal treatment plus 7-day high dose primaquine (total dose 7mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 33252490

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 32622585

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 36436076

Group type: EXPERIMENTAL
Intervention: Costoclavicular brachial plexus block (CC group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Supraclavicular brachial plexus block (SC group)
Number of subjects: 56
Study: 34180574

Group type: EXPERIMENTAL
Intervention: 37.5% hydrogen peroxide (37.5HP) in-office bleaching with two 8-min applications/clinical session
Number of subjects: 40

Group type: COMPARATOR
Intervention: 37.5% hydrogen peroxide (37.5HP) in-office bleaching with three 8-min applications/clinical session
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatment groups (two and three applications)
Number of subjects: 40
Study: 33268603

Group type: EXPERIMENTAL
Intervention: Distal protection (DP)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Conventional treatment (CT)
Number of subjects: 194
Study: 35405965

Group type: EXPERIMENTAL
Intervention: Green mandarin extract (PTE) 300 mg/day for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35702003

Group type: EXPERIMENTAL
Intervention: MIHOW (Maternal Infant Health Outreach Worker program)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Minimal Education Intervention (MEI)
Number of subjects: 132
Study: 32952034

Group type: EXPERIMENTAL
Intervention: Test lecture utilizing metaphoric radiology signs
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control lecture without metaphoric signs
Number of subjects: 49
Study: 32234247

Group type: EXPERIMENTAL
Intervention: 20-min rounding intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: All aged care sites (combined data)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 41
Study: 36190186

Group type: EXPERIMENTAL
Intervention: dd-cfDNA
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: DSA
Number of subjects: 280

Group type: COMPARATOR
Intervention: Both dd-cfDNA and DSA
Number of subjects: 280
Study: 32857210

Group type: EXPERIMENTAL
Intervention: Selective removal (SE)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Stepwise removal (SW)
Number of subjects: 74
Study: 32348796

Group type: EXPERIMENTAL
Intervention: Upward comparison (participants told they received a worse meal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control comparison (participants told they received the same meal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Downward comparison (participants told they received a better meal)
Number of subjects: 0
Study: 35313112

Group type: EXPERIMENTAL
Intervention: Ophthalmologic procedures
Number of subjects: 806

Group type: COMPARATOR
Intervention: Control period (8-day period 30 days earlier)
Number of subjects: 806
Study: 33809277

Group type: EXPERIMENTAL
Intervention: Personalized telerehabilitation intervention after hospital discharge
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard health education and/or care in a rehabilitation center
Number of subjects: 0
Study: 32490272

Group type: EXPERIMENTAL
Intervention: High socio-environmental status
Number of subjects: 2445

Group type: EXPERIMENTAL
Intervention: Educational level
Number of subjects: 2445

Group type: EXPERIMENTAL
Intervention: Economic level
Number of subjects: 2445
Study: 35794120

Group type: EXPERIMENTAL
Intervention: Exercises + Kinesio taping
Number of subjects: 58

Group type: COMPARATOR
Intervention: Exercises + Analgesic current
Number of subjects: 58
Study: 34034400

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with suplatast tosilate, started 2 weeks before pollen season.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group with no prophylactic treatment.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with suplatast tosilate.
Number of subjects: 34
Study: 35270768

Group type: EXPERIMENTAL
Intervention: Blended learning group (face-to-face intervention + gamified e-learning module)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (gamified e-learning module only)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Blended learning group
Number of subjects: 65
Study: 33322161

Group type: EXPERIMENTAL
Intervention: Postoperative educational intervention program
Number of subjects: 224

Group type: COMPARATOR
Intervention: Routine management without educational program (Control)
Number of subjects: 224
Study: 32796417

Group type: EXPERIMENTAL
Intervention: Integrative neuromuscular training (INT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 38
Study: 33217805

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham kinesio taping (sham KT)
Number of subjects: 0
Study: 33277736

Group type: EXPERIMENTAL
Intervention: Bundled self-management intervention (4Ds)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study: 33114364

Group type: EXPERIMENTAL
Intervention: WS group 1 (500 mL purified water)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: WS group 2 (200 mL purified water)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: WS group 3 (100 mL purified water)
Number of subjects: 64

Group type: COMPARATOR
Intervention: NW group (no water supplementation)
Number of subjects: 64
Study: 34423506

Group type: EXPERIMENTAL
Intervention: Functional correction training based on FMS scores in Group A
Number of subjects: 420

Group type: COMPARATOR
Intervention: No intervention measures in Group B
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Functional correction training in Group A
Number of subjects: 420
Study: 32275060

Group type: EXPERIMENTAL
Intervention: COMPASS-TC transitional care model
Number of subjects: 19
Study: 34321046

Group type: EXPERIMENTAL
Intervention: Educational films intervention
Number of subjects: 10000
Study: 33028223

Group type: EXPERIMENTAL
Intervention: Preoperative walking intervention with remote coaching and pedometer
Number of subjects: 120

Group type: COMPARATOR
Intervention: General walking advice (Control)
Number of subjects: 120
Study: 35785477

Group type: EXPERIMENTAL
Intervention: 8-week dietary weight-loss intervention
Number of subjects: 52
Study: 33493551

Group type: EXPERIMENTAL
Intervention: Whole blood (WB) method
Number of subjects: 664

Group type: COMPARATOR
Intervention: Peripheral blood mononuclear cells (PBMC) method
Number of subjects: 664
Study: 33454114

Group type: EXPERIMENTAL
Intervention: Ultrasonic cleaning
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Soaking
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Wiping
Number of subjects: 48
Study: 34118426

Group type: EXPERIMENTAL
Intervention: Consecutive recruitment (approaching recently seen eligible patients in consecutive order by date seen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional recruitment (such as posters, flyers, tear‐offs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 32414353

Group type: EXPERIMENTAL
Intervention: Pathogenic/likely pathogenic variant in a gene associated with adult-onset disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pathogenic/likely pathogenic variant in a gene associated with pediatric-onset disease or with risk reduction interventions that begin in childhood
Number of subjects: 0

Group type: COMPARATOR
Intervention: No apparent genomic result, sex- and age-matched to Groups 1 and 2
Number of subjects: 0
Study: 34382318

Group type: EXPERIMENTAL
Intervention: Shanley Pressure Ulcer Prevention Programme (SPUPP) - a multimedia programme delivered over 5 weeks with 5 sessions using electronic media, hard copy materials, activities, and patient diaries.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Shanley Pressure Ulcer Prevention Programme (SPUPP) - a multimedia programme delivered over 5 weeks.
Number of subjects: 64
Study: 32078484

Group type: EXPERIMENTAL
Intervention: LDL cholesterol <70 mg/dL
Number of subjects: 1073

Group type: COMPARATOR
Intervention: LDL cholesterol 100±10 mg/dL (90-110 mg/dL)
Number of subjects: 1073
Study: 34907783

Group type: EXPERIMENTAL
Intervention: Acute cycling bout in normoxia
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Acute cycling bout in hypoxia
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (prediabetic subjects)
Number of subjects: 32
Study: 33799037

Group type: EXPERIMENTAL
Intervention: Psychological therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morning cortisol
Number of subjects: 0
Study: 32767902

Group type: EXPERIMENTAL
Intervention: Mobile learning approach (test taken free of local or temporal fixations)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional testing conditions (test taken at the local testing center)
Number of subjects: 0
Study: 36376167

Group type: EXPERIMENTAL
Intervention: uMGMT/CAP (arm A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: uMGMT/TMZ + CAP (arm B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: mMGMT/CAP (arm C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: mMGMT/TMZ + CAP (arm D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: CAP group (arms A + C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: TMZ + CAP group (arms B + D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: uMGMT group (arms A + B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: mMGMT group (arms C + D)
Number of subjects: 60
Study: 34288017

Group type: EXPERIMENTAL
Intervention: Composite outcome of further bleeding within 30 days after randomisation leading to red blood cell transfusion, urgent intervention (repeat endoscopy; interventional radiology or surgery), or death
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual components of the primary outcome
Number of subjects: 0
Study: 32933153

Group type: EXPERIMENTAL
Intervention: Krill Oil (KO) 1.27 g/day of long-chain omega-3 PUFA (0.76 g EPA, 0.42 g DHA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Fish Oil (FO) 1.44 g/day of long-chain omega-3 PUFA (0.79 g EPA, 0.47 g DHA)
Number of subjects: 11
Study: 35932394

Group type: EXPERIMENTAL
Intervention: Integrated intervention targeting financial distress and tobacco use (financial coaching and social services referrals)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Control group (standard smoking cessation treatment)
Number of subjects: 410
Study: 34391302

Group type: EXPERIMENTAL
Intervention: Maitland's mobilization
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mulligan's mobilization
Number of subjects: 40
Study: 33890883

Group type: EXPERIMENTAL
Intervention: Active filtration system (Revolve; LifeCell Corporation)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Passive filtration system (PureGraft 250; Cytori Therapeutics)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Centrifugation
Number of subjects: 46
Study: 32202943

Group type: EXPERIMENTAL
Intervention: Absolute PASI ≤ 2, N = 548
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: 90% improvement in PASI, N = 559
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Absolute PASI and PASI response
Number of subjects: 1054
Study: 36442806

Group type: EXPERIMENTAL
Intervention: Jump Start+: COVID 19 Support (JS + CS) virtual toolkit delivered via Kubi robot
Number of subjects: 0

Group type: COMPARATOR
Intervention: Obesity prevention intervention (control group)
Number of subjects: 0
Study: 34560858

Group type: EXPERIMENTAL
Intervention: Health Education Based Intervention (HEBI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35439608

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg once daily
Number of subjects: 0
Study: 33279353

Group type: EXPERIMENTAL
Intervention: Cryoneurolysis
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 124
Study: 33588669

Group type: EXPERIMENTAL
Intervention: Digital care management
Number of subjects: 0
Study: 32305424

Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA)
Number of subjects: 5554

Group type: COMPARATOR
Intervention: Steroids
Number of subjects: 5554

Group type: COMPARATOR
Intervention: Single Platelet-Rich Plasma (PRP)
Number of subjects: 5554

Group type: COMPARATOR
Intervention: Multiple PRP
Number of subjects: 5554

Group type: COMPARATOR
Intervention: Adipose Mesenchymal Stromal Cells (MSC)
Number of subjects: 5554

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 5554
Study: 36353183

Group type: EXPERIMENTAL
Intervention: Contact time gait-training feedback with home exercises (FBHE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Home exercises (HE)
Number of subjects: 20
Study: 32251036

Group type: EXPERIMENTAL
Intervention: Health literacy-directed intervention in a randomized controlled trial for colorectal cancer screening.
Number of subjects: 0
Study: 34897593

Group type: EXPERIMENTAL
Intervention: Zhuang medicine medicated thread moxibustion (ZMTM) combined with Western medicines
Number of subjects: 241

Group type: COMPARATOR
Intervention: Western medicines alone (pidotimod dispersible tablets, vitamin B compound tablets, compound cod liver oil‐zinc oxide ointment)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: ZMTM combined with Western medicines
Number of subjects: 241
Study: 33217374

Group type: EXPERIMENTAL
Intervention: Soft orthotics
Number of subjects: 44

Group type: COMPARATOR
Intervention: Hard orthotics
Number of subjects: 44
Study: 34967864

Group type: EXPERIMENTAL
Intervention: tSVF injection in the lateral 5 cm of the horizontal scar of 1 breast
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo injection in the contralateral breast
Number of subjects: 40
Study: 34191437

Group type: EXPERIMENTAL
Intervention: Genetically predicted educational attainment
Number of subjects: 20926

Group type: EXPERIMENTAL
Intervention: Circulating mono‐unsaturated fatty acid concentrations
Number of subjects: 20926

Group type: EXPERIMENTAL
Intervention: C‐reactive protein (CRP)
Number of subjects: 20926

Group type: EXPERIMENTAL
Intervention: High‐density lipoprotein (HDL)
Number of subjects: 20926

Group type: EXPERIMENTAL
Intervention: Triglycerides
Number of subjects: 20926

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP)
Number of subjects: 20926